Cargando…
Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers
The mRNA vaccines against COVID-19 infection have been effective in reducing the number of symptomatic cases worldwide. With widespread uptake, case series of vaccine-related myocarditis/pericarditis have been reported, particularly in adolescents and young adults. Men tend to be affected with great...
Autores principales: | Luk, Adriana, Clarke, Brian, Dahdah, Nagib, Ducharme, Anique, Krahn, Andrew, McCrindle, Brian, Mizzi, Trent, Naus, Monika, Udell, Jacob A., Virani, Sean, Zieroth, Shelley, McDonald, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Canadian Cardiovascular Society. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349442/ https://www.ncbi.nlm.nih.gov/pubmed/34375696 http://dx.doi.org/10.1016/j.cjca.2021.08.001 |
Ejemplares similares
-
Optimizing Access to Heart Failure Care in Canada During the COVID-19 Pandemic
por: Virani, Sean A., et al.
Publicado: (2020) -
Cardiovascular Care Delivery During the Second Wave of COVID-19 in Canada
por: Roifman, Idan, et al.
Publicado: (2021) -
Severe myocarditis after SARS-CoV-2 vaccination in a 49-year-old woman
por: Olmos, Carla Vallejos, et al.
Publicado: (2022) -
Guiding Cardiac Care During the COVID-19 Pandemic: How Ethics Shapes Our Health System Response
por: Virani, Alice, et al.
Publicado: (2020) -
Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team
por: Paterson, Ian, et al.
Publicado: (2021)